Stratec SE (0RAR.L)
EUR 24.95
(-0.99%)
EUR 24.95
(-0.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 142.62 Million EUR | 21.25% |
| 2022 | 117.63 Million EUR | 32.51% |
| 2021 | 88.76 Million EUR | 30.49% |
| 2020 | 68.02 Million EUR | 21.52% |
| 2019 | 55.97 Million EUR | -4.36% |
| 2018 | 58.53 Million EUR | 109.94% |
| 2017 | 27.88 Million EUR | 13.71% |
| 2016 | 24.51 Million EUR | 53.06% |
| 2015 | 16.01 Million EUR | -11.33% |
| 2014 | 18.06 Million EUR | -0.14% |
| 2013 | 18.09 Million EUR | -58.95% |
| 2012 | 44.07 Million EUR | 11.71% |
| 2011 | 39.45 Million EUR | 12.2% |
| 2010 | 35.16 Million EUR | 11.93% |
| 2009 | 31.41 Million EUR | 30.38% |
| 2008 | 24.09 Million EUR | 50.64% |
| 2007 | 15.99 Million EUR | 8.92% |
| 2006 | 14.68 Million EUR | 15.33% |
| 2005 | 12.73 Million EUR | 17.33% |
| 2004 | 10.85 Million EUR | -11.28% |
| 2003 | 12.23 Million EUR | 108436.4% |
| 2002 | 11.27 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 148.95 Million EUR | 4.48% |
| 2024 Q2 | 142.56 Million EUR | -5.74% |
| 2024 Q1 | 151.24 Million EUR | 6.05% |
| 2023 Q3 | 139.8 Million EUR | 6.67% |
| 2023 FY | 142.62 Million EUR | 21.25% |
| 2023 Q1 | 128.57 Million EUR | 9.31% |
| 2023 Q2 | 131.06 Million EUR | 1.93% |
| 2023 Q4 | 142.62 Million EUR | 2.02% |
| 2022 FY | 117.63 Million EUR | 32.51% |
| 2022 Q1 | 89.24 Million EUR | 0.54% |
| 2022 Q2 | 98.96 Million EUR | 10.89% |
| 2022 Q3 | 114.03 Million EUR | 15.23% |
| 2022 Q4 | 117.63 Million EUR | 3.15% |
| 2021 Q1 | 74.67 Million EUR | 9.77% |
| 2021 FY | 88.76 Million EUR | 30.49% |
| 2021 Q2 | 76.21 Million EUR | 2.07% |
| 2021 Q3 | 84.6 Million EUR | 11.01% |
| 2021 Q4 | 88.76 Million EUR | 4.92% |
| 2020 FY | 68.02 Million EUR | 21.52% |
| 2020 Q1 | 58.03 Million EUR | 3.67% |
| 2020 Q2 | 62.92 Million EUR | 8.43% |
| 2020 Q3 | 70.43 Million EUR | 11.94% |
| 2020 Q4 | 68.02 Million EUR | -3.43% |
| 2019 FY | 55.97 Million EUR | -4.36% |
| 2019 Q3 | 59.62 Million EUR | 8.5% |
| 2019 Q2 | 54.95 Million EUR | -9.67% |
| 2019 Q4 | 55.97 Million EUR | -6.12% |
| 2019 Q1 | 60.84 Million EUR | 3.95% |
| 2018 Q1 | 36.18 Million EUR | 29.78% |
| 2018 FY | 58.53 Million EUR | 109.94% |
| 2018 Q4 | 58.53 Million EUR | 5.82% |
| 2018 Q2 | 47.08 Million EUR | 30.14% |
| 2018 Q3 | 55.3 Million EUR | 17.46% |
| 2017 Q1 | 27.45 Million EUR | 11.95% |
| 2017 FY | 27.88 Million EUR | 13.71% |
| 2017 Q4 | 27.88 Million EUR | -8.23% |
| 2017 Q3 | 30.38 Million EUR | 7.05% |
| 2017 Q2 | 28.37 Million EUR | 3.38% |
| 2016 Q4 | 24.51 Million EUR | -7.31% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 25.73 Million EUR | 0.0% |
| 2016 FY | 24.51 Million EUR | 53.06% |
| 2016 Q3 | 26.45 Million EUR | 2.79% |
| 2015 Q4 | 16.01 Million EUR | -19.86% |
| 2015 Q1 | 17.73 Million EUR | -1.86% |
| 2015 FY | 16.01 Million EUR | -11.33% |
| 2015 Q2 | 19.15 Million EUR | 8.06% |
| 2015 Q3 | 19.98 Million EUR | 4.33% |
| 2014 Q3 | 20.07 Million EUR | 6.01% |
| 2014 FY | 18.06 Million EUR | -0.14% |
| 2014 Q1 | 19.4 Million EUR | 7.26% |
| 2014 Q4 | 18.06 Million EUR | -9.99% |
| 2014 Q2 | 18.93 Million EUR | -2.44% |
| 2013 Q3 | 49.14 Million EUR | 3.9% |
| 2013 Q1 | 47.37 Million EUR | 7.49% |
| 2013 FY | 18.09 Million EUR | -58.95% |
| 2013 Q4 | 18.09 Million EUR | -63.19% |
| 2013 Q2 | 47.29 Million EUR | -0.16% |
| 2012 Q3 | 47.52 Million EUR | 9.28% |
| 2012 Q4 | 44.07 Million EUR | -7.27% |
| 2012 Q2 | 43.48 Million EUR | 6.02% |
| 2012 Q1 | 41.02 Million EUR | 3.98% |
| 2012 FY | 44.07 Million EUR | 11.71% |
| 2011 Q4 | 39.45 Million EUR | -7.82% |
| 2011 Q2 | 43.51 Million EUR | 7.93% |
| 2011 Q3 | 42.79 Million EUR | -1.64% |
| 2011 FY | 39.45 Million EUR | 12.2% |
| 2011 Q1 | 40.31 Million EUR | 14.66% |
| 2010 FY | 35.16 Million EUR | 11.93% |
| 2010 Q1 | 36.94 Million EUR | 17.6% |
| 2010 Q3 | 41.76 Million EUR | 3.69% |
| 2010 Q4 | 35.16 Million EUR | -15.81% |
| 2010 Q2 | 40.27 Million EUR | 9.03% |
| 2009 FY | 31.41 Million EUR | 30.38% |
| 2009 Q4 | 31.41 Million EUR | 0.0% |
| 2008 FY | 24.09 Million EUR | 50.64% |
| 2007 FY | 15.99 Million EUR | 8.92% |
| 2006 FY | 14.68 Million EUR | 15.33% |
| 2005 FY | 12.73 Million EUR | 17.33% |
| 2004 FY | 10.85 Million EUR | -11.28% |
| 2003 FY | 12.23 Million EUR | 108436.4% |
| 2002 FY | 11.27 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cegedim SA | 9.2 Million EUR | -1450.103% |
| Guerbet SA | 305.17 Million EUR | 53.265% |
| Nexus AG | 3.22 Million EUR | -4319.74% |
| Bastide Le Confort Médical SA | 43.2 Million EUR | -230.097% |
| Revenio Group Oyj | 10.5 Million EUR | -1258.333% |
| Drägerwerk AG & Co. KGaA | 657.88 Million EUR | 78.321% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 86.242% |
| LNA Santé SA | 148.29 Million EUR | 3.825% |
| Siemens Healthineers AG | 4.26 Billion EUR | 96.653% |
| Medios AG | 60.43 Million EUR | -135.99% |
| Equasens Société anonyme | 10.31 Million EUR | -1282.829% |